Longevity Health Holdings, Inc.
For the period ended Mar 31, 2026. Filed May 15, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 15, 2026
XAGE$0.23-13.1%Stored close · as of Jul 8, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Financial Statements Condensed Consolidated Balance Sheets
CONDENSED CONSOLIDATED BALANCE SHEETS
| March 31, | December 31, | |
|---|---|---|
| 2026 | 2025 | |
| (unaudited) | ||
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $313,396 | $706,740 |
| Accounts receivable | 48,665 | 36,500 |
| Inventory | 734,968 | 963,028 |
| Prepaid expenses | 165,748 | 243,823 |
| Total current assets | 1,262,777 | 1,950,091 |
| Operating lease right of use asset | 277,939 | 300,221 |
| Property and equipment, net of accumulated depreciation of $789,685 and $775,783, respectively | 87,719 | 101,621 |
| Intangible assets, net of accumulated amortization of $56,788 and $55,652, respectively | 13,958 | 15,094 |
| Total assets | $1,642,393 | $2,367,027 |
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||
| Current liabilities: | ||
| Accounts payable | $5,046,277 | $4,494,923 |
| Accrued expenses and other liabilities | 1,858,576 | 1,843,464 |
| Accrued interest | 1,175,845 | 1,175,845 |
| Loans payable | 115,342 | 189,939 |
| Earnout liabilities | 55,996 | 49,153 |
| Operating lease liability | 97,110 | 95,193 |
| Consideration payable | — | 67,742 |
| Total current liabilities | 8,349,146 | 7,916,259 |
| Long-term liabilities: | ||
| Earnout liabilities, net of current portion | — | 102,896 |
| Operating lease liability, net of current portion | 188,163 | 214,745 |
| Total liabilities | 8,537,309 | 8,233,900 |
| Commitments and contingencies (see Note 9) | ||
| Stockholders’ deficit: | ||
| Series A convertible voting preferred stock, $0.0001 par value; 4,243 shares authorized, -0- shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | — | — |
| Common stock, $0.0001 par value; 250,000,000 shares authorized, 2,475,321 and 1,781,738 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 247 | 178 |
| Additional paid-in capital | 70,313,494 | 69,909,893 |
| Accumulated deficit | (77,208,657) | (75,776,944) |
| Total stockholders’ deficit | (6,894,916) | (5,866,873) |
| Total liabilities and stockholders’ deficit | $1,642,393 | $2,367,027 |
-3-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.